Copertina

NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Shaomin Zou, Yizhi Huang, Ziqing Yang, Jieping Zhang, Manqi Meng, Yijing Zhang, Junyan Feng, Rui Sun, Weiyao Li, Wencong Wang, Jesús García‐Foncillas López, Lekun Fang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical and Translational Medicine
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m6A modification of ANKRD22 mRNA
di: Lvyuan Li, et al.
Pubblicazione: (2024)

N6‐methyladenosine‐modified circTEAD1 stabilizes Yap1 mRNA to promote chordoma tumorigenesis
di: Hanwen Li, et al.
Pubblicazione: (2024)

PUS7‐dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression
di: Yongxia Chang, et al.
Pubblicazione: (2024)

Extrachromosomal circular DNA expressing miRNA promotes ovarian cancer progression
di: Ning Wu, et al.
Pubblicazione: (2025)

Transcriptomic miRNA and mRNA signatures in primary prostate cancer that are associated with lymph‐node invasion
di: Matias A. Bustos, et al.
Pubblicazione: (2025)

LRPPRC promotes glycolysis by stabilising LDHA mRNA and its knockdown plus glutamine inhibitor induces synthetic lethality via m6A modification in triple‐negative breast cancer
di: Yuanhang Yu, et al.
Pubblicazione: (2024)

SKA3/PTTG1/c‐MYC signal loop drives the progression of colorectal cancer
di: Hao Zhang, et al.
Pubblicazione: (2024)

Translational inhalable extracellular vesicle‐based mRNA therapy for the treatment of lung cancer
di: Mengrui Liu, et al.
Pubblicazione: (2025)

Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticles
di: Qiang Chen, et al.
Pubblicazione: (2024)

RNF39 promotes colorectal cancer progression by driving RINT1 degradation and suppressing ER stress‐induced apoptosis
di: Lu Chen, et al.
Pubblicazione: (2025)

Thyroglobulin mRNA ectopic expression was an excellent marker to detect lymph node metastasis for patients with papillary thyroid cancer
di: Wen‐Hua Du, et al.
Pubblicazione: (2025)

Neutrophil extracellular traps promote growth of lung adenocarcinoma by mediating the stability of m6A‐mediated SLC2A3 mRNA‐induced ferroptosis resistance and CD8(+) T cell inhibition
di: Li Xu, et al.
Pubblicazione: (2025)

Circular RNA LIPH promotes pancreatic cancer glycolysis and progression through sponge miR‐769‐3p and interaction with GOLM1
di: Yan Ma, et al.
Pubblicazione: (2024)

CircHPCAL1 promotes the progression of pancreatic cancer via the regulation of STEAP2
di: Xiaomeng He, et al.
Pubblicazione: (2025)

Parvimonas micra promotes carcinogenesis of colorectal cancer through phenyllactic acid‐induced DNA damage
di: Shuang Guo, et al.
Pubblicazione: (2026)

Investigating the impact of hypoxia and syncytialization on lipid nanoparticle‐mediated mRNA delivery to placental cells
di: Rachel E. Young, et al.
Pubblicazione: (2026)

Translational pharmacokinetic/pharmacodynamic model for mRNA‐0184, an investigational therapeutic for the treatment of heart failure
di: Neeraj Kaushal, et al.
Pubblicazione: (2024)

Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3/GSDMD‐mediated pyroptosis in colorectal cancer
di: Xin Guan, et al.
Pubblicazione: (2024)

The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients
di: Fredrika Hellgren, et al.
Pubblicazione: (2026)

Engineering biomimetic nanovesicles for PEBP1 mRNA delivery to inhibit ferroptosis in abdominal aortic aneurysm
di: Lulu Chen, et al.
Pubblicazione: (2025)

Decoding innate lymphoid cell heterogeneity and plasticity in colorectal cancer
di: Shuomin Zhang, et al.
Pubblicazione: (2026)

Cyclin‐dependent kinase 12 deficiency reprogrammes cellular metabolism to alleviate ferroptosis potential and promote the progression of castration‐resistant prostate cancer
di: Haozhe Zhang, et al.
Pubblicazione: (2024)

RNA splicing factor RBFOX2 is a key factor in the progression of cancer and cardiomyopathy
di: Jinze Shen, et al.
Pubblicazione: (2024)

PVT1‐104aa derived from the 8q24 gene desert promotes colorectal cancer tumorigenesis
di: Maoguang Ma, et al.
Pubblicazione: (2026)

Snai2‐mediated upregulation of NADSYN1 promotes bladder cancer progression by interacting with PHB
di: Li‐Juan Jiang, et al.
Pubblicazione: (2024)

Feedback regulation between histone H3 lysine 18 lactylation and TROP2‐mediated glycolysis drives metastatic progression of colorectal cancer
di: Weifeng Wang, et al.
Pubblicazione: (2026)

Durability of Response to B‐Cell Maturation Antigen‐Directed mRNA Cell Therapy in Myasthenia Gravis
di: Nizar Chahin, et al.
Pubblicazione: (2025)

METTL14‐mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination
di: Zhuonan Liu, et al.
Pubblicazione: (2025)

Bioinspired oxidized mRNA lipid nanoparticles for ex vivo engineering of chimeric antigen receptor macrophages targeting solid tumors
di: Alvin J. Mukalel, et al.
Pubblicazione: (2026)

Enhancement of anti‐sarcoma immunity by NK cells engineered with mRNA for expression of a EphA2‐targeted CAR
di: Pui Yeng Lam, et al.
Pubblicazione: (2025)

Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
di: Zheng Wu, et al.
Pubblicazione: (2025)

IGF2BP2 binding to CPSF6 facilitates m6A‐mediated alternative polyadenylation of PUM2 and promotes malignant progression in ovarian cancer
di: Xin Luo, et al.
Pubblicazione: (2025)

Translational PK–PD model for in vivo CAR‐T‐cell therapy delivered using CAR mRNA‐loaded polymeric nanoparticle vector
di: Se Jin Kim, et al.
Pubblicazione: (2024)

LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53‐driven tumour progression through miR‐5683/FGF2
di: Nannan Liu, et al.
Pubblicazione: (2024)

M6A demethylase ALKBH5 mediated Igfbp4 mRNA m6A modification drives fibroblast activation and pathological upper airway fibrosis
di: Jing Wang, et al.
Pubblicazione: (2026)

Synthetic lethality in cancer therapy: Mechanisms, models and clinical translation for overcoming therapeutic resistance
di: Junyan Li, et al.
Pubblicazione: (2026)

Imbalanced NK cell subpopulations and TIGIT expression limit cetuximab efficacy in colorectal cancer: A promising target for treatment enhancement
di: Carmen Navarrete‐Sirvent, et al.
Pubblicazione: (2025)

CXCR5 and TLR4 signals synergistically enhance non‐small cell lung cancer progression
di: Ji Hye Shin, et al.
Pubblicazione: (2024)

Copper in colorectal cancer: From copper‐related mechanisms to clinical cancer therapies
di: Yuhong Wang, et al.
Pubblicazione: (2024)

Histone lactylation‐mediated up‐regulation of IGF2BP2 enhances ferroptosis resistance via Nrf2 in colorectal cancer
di: Jin‐Feng Zhu, et al.
Pubblicazione: (2025)